0 Σχόλια
0 Μοιράστηκε
319 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Meningococcal Vaccines Market Forecast: Industry Developments, Demand, and Growth ProspectsThe Meningococcal Vaccines Market is expected to experience continued growth as healthcare systems prioritize infectious disease prevention and vaccine innovation. Market Research Future projects that the market will rise from USD 3.34 billion in 2025 to USD 6.48 billion by 2035, registering a CAGR of 7.62% during 2026–2035. Future growth will be shaped by improvements in vaccine...0 Σχόλια 0 Μοιράστηκε 177 Views 0 Προεπισκόπηση
-
South America Meningococcal Vaccines Market Growth, Competitive Landscape & Forecast Report 2035The South America Meningococcal Vaccines Market is experiencing steady growth as governments, healthcare organizations, and vaccine manufacturers intensify efforts to prevent meningococcal disease across the region. Meningococcal vaccines play a vital role in protecting individuals from severe bacterial infections caused by Neisseria meningitidis, which can lead to meningitis and bloodstream...0 Σχόλια 0 Μοιράστηκε 247 Views 0 Προεπισκόπηση
-
Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...0 Σχόλια 0 Μοιράστηκε 667 Views 0 Προεπισκόπηση
-
The Global Meningococcal Vaccines Market Size Was Valued at USD 3.73 Billion in 2023 and is Projected to Reach USD 8.80 Billion by 2032The Global Meningococcal Vaccines Market Size Was Valued at USD 3.73 Billion in 2023 and is Projected to Reach USD 8.80 Billion by 2032, Growing at a CAGR of 10.02%. Meningococcal vaccines are critical biological preparations designed to protect individuals against diseases caused by the bacterium Neisseria meningitidis, which can lead to life-threatening conditions like meningitis and...0 Σχόλια 0 Μοιράστηκε 738 Views 0 Προεπισκόπηση